The GIP and glucagon components specifically target metabolic dysfunction, providing additional benefit beyond appetite suppression for this population
But sometimes the answer is that the product is not what it claims to be
Speaking on the Not Skinny But Not Fat podcast earlier this year, their sister Kourtney Kardashian, 43, dished on the change in her and Khloe's dynamic
These are valid questions and deserve complete answers
From Phase 3 obesity contenders and oral GLP-1 breakthroughs to reframing liver and brain risk, this week reinforces a clear shift: metabolic disease care is becoming broader, earlier, and far more integrated
In addition, some putative effects of GLP-1RAs on cognitive and mental health symptoms may not require direct activity in the CNS, but rather be mediated by the actions that these medications express in the periphery across immune, endocrinemetabolic and gutbrain axis mechanisms (Fig